[
Hengrui’s debut, which comes on the heels of CATL’s blockbuster Hong Kong premiere, builds on Hong Kong’s hot listings market—where proceeds are forecast to double to more than $22 billion this year.
May James—SOPA Images/LightRocket via Getty Images
https://fortune.com/img-assets/wp-content/uploads/2025/05/GettyImages-2209023519-e1747984384247.jpg?resize=1200,600
https://fortune.com/asia/2025/05/23/top-chinese-drugmaker-hengrui-soars-in-hong-kong-trading-debut/
Amber Tong, Bloomberg
